Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans(2018)Auteurs: Peter Ulrichts, Antonio Guglietta, Torsten Dreier, Tonke van Bragt, Valerie Hanssens, Erik Hofman, Bernhardt Vankerckhoven, Peter Verheesen, Nicolas Ongenae, Valentina Lykhopiy, et al.
Pagina's: 4372 - 4386
